ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Cashtrain
|
261 |
66K |
23 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
66K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Cashtrain
|
261 |
66K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
66K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Cashtrain
|
261 |
66K |
11 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
66K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Cashtrain
|
261 |
66K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
66K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Cashtrain
|
32 |
9.3K |
3 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
32
|
9.3K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Cashtrain
|
32 |
9.3K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
32
|
9.3K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Cashtrain
|
32 |
9.3K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
32
|
9.3K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Cashtrain
|
1.3K |
331K |
12 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.3K
|
331K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Cashtrain
|
1.3K |
331K |
12 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
1.3K
|
331K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Cashtrain
|
12 |
2.7K |
7 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.7K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Cashtrain
|
12 |
2.7K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.7K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Cashtrain
|
12 |
2.7K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.7K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Cashtrain
|
12 |
2.7K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.7K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
19K |
9 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
19K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
19K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
19K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
19K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
19K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
19K |
11 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
19K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Cashtrain
|
77 |
19K |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
19K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Cashtrain
|
1.3K |
331K |
11 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.3K
|
331K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Cashtrain
|
55 |
14K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
14K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Cashtrain
|
55 |
14K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
14K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Cashtrain
|
31 |
11K |
4 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
11K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Cashtrain
|
31 |
11K |
14 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
11K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Cashtrain
|
31 |
11K |
9 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
11K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Cashtrain
|
282 |
74K |
10 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
282
|
74K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Cashtrain
|
197 |
52K |
21 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
197
|
52K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Cashtrain
|
126 |
31K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Cashtrain
|
126 |
31K |
16 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
31K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
212 |
40K |
8 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
212
|
40K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
212 |
40K |
15 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
212
|
40K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
212 |
40K |
7 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
212
|
40K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
212 |
40K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
212
|
40K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
212 |
40K |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
212
|
40K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
212 |
40K |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
212
|
40K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
212 |
40K |
7 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
212
|
40K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
317 |
80K |
8 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
317
|
80K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Cashtrain
|
63 |
16K |
14 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
16K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Cashtrain
|
39 |
9.3K |
7 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.3K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Cashtrain
|
282 |
74K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
282
|
74K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Cashtrain
|
39 |
9.3K |
9 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
39
|
9.3K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
15K |
17 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
58
|
15K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
15K |
15 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
15K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
15K |
10 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
15K |
21 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
15K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
15K |
10 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Cashtrain
|
77 |
20K |
8 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
77
|
20K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
317 |
80K |
10 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
317
|
80K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
317 |
80K |
13 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
317
|
80K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
317 |
80K |
3 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
317
|
80K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
317 |
80K |
6 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
317
|
80K
|
6
|
|